Journal
FRONTIERS IN ONCOLOGY
Volume 7, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2017.00040
Keywords
epithelial-to-mesenchymal transition; metabolic reprogramming; Warburg metabolism; OXPHOS; TCA cycle; oncometabolites; amino acid; lipids
Categories
Funding
- Fondazione Umberto Veronesi
- Associazione Italiana Ricerca sul Cancro (AIRC) [8797]
- AIRC
- Fondazione Cassa di Risparmio di Firenze [19515]
- Istituto Toscano Tumori [0203607]
- Programma operativo regionale Obiettivo Competitivita regionale e occupazione della Regione Toscana cofinanziato dal Fondo europeo di sviluppo regionale (POR CReO FESR)
Ask authors/readers for more resources
The epithelial-to-mesenchymal transition (EMT) process allows the trans-differentiation of a cell with epithelial features into a cell with mesenchymal characteristics. This process has been reported to be a key priming event for tumor development and therefore EMT activation is now considered an established trait of malignancy. The transcriptional and epigenetic reprogramming that governs EMT has been extensively characterized and reviewed in the last decade. However, increasing evidence demonstrates a correlation between metabolic reprogramming and EMT execution. The aim of the current review is to gather the recent findings that illustrate this correlation to help deciphering whether metabolic changes are causative or just a bystander effect of EMT activation. The review is divided accordingly to the catabolic and anabolic pathways that characterize carbohydrate, aminoacid, and lipid metabolism. Moreover, at the end of each part, we have discussed a series of potential metabolic targets involved in EMT promotion and execution for which drugs are either available or that could be further investigated for therapeutic intervention.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available